Mitsubishi Tanabe Pharma America
Kinjal Patel has an extensive background in medical affairs operations, with experience in leading clinical trials, managing global teams, and driving launch management priorities across various therapeutic areas such as Central Nervous System and Rare Diseases. With a Master's degree in Healthcare Administration and an MBA, Kinjal has held key positions at pharmaceutical companies such as Mitsubishi Tanabe Pharma America, Bayer, Bristol Myers Squibb, Novartis, and more, showcasing a strong track record of success in the pharmaceutical industry.
Mitsubishi Tanabe Pharma America
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf